Search Results for

A032002

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

Continue Reading »

---

S2011

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Continue Reading »

---

A031901

Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy

Continue Reading »

---

EA8185

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, the INSPIRE Study

Continue Reading »

---

A031702

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Continue Reading »

---

S1806

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Continue Reading »

---

Search Again

• All Trial Categories Anal  (2) Bladder/Urinary Tract Cancer  (6)    Metastatic  (3)    Neoadjuvant  (2) Brain  (9)    Glioblastoma Multiforme (GBM)  (3)    Other Brain Tumors  (3) Breast  (7)    Breast Cancer Adjuvant  (2)    DCIS/LCIS  (1) Cancer Control/Symptom Management  (23) Carcinoid Tumors  (1) Colorectal Cancer  (8)    Metastatic  (2)    Rectal Neoadjuvant  (1) Esophageal Cancer  (1) Gall Bladder/ Biliary Tract Cancer  (1) Head/Neck Cancer  (6) Leukemia  (1)    Acute Myeloid Leukemia (AML)  (1) Liver/Hepatocellular Carcinoma  (1) Lung Cancer  (22)    Non-Small Cell Lung Cancer  (16)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (4)       2nd Line Metastatic, Stage 4 Patients with Progressive Disease  (3)       Adjuvant Treatment for Resected NSCLC  (4)    Small Cell Lung Cancer  (6)       Extensive Stage SCLC  (4) Lymphoma  (2)    Non-Hodgkin’s Lymphoma  (1) MDS  (1) Melanoma  (1) Merkel Cell Carcinoma  (1) Multiple Myeloma  (2) Ovarian  (1) Pancreatic  (5)    Metastatic Disease  (2) Prostate  (10) Renal Cell/Kidney Cancer  (3)    Locally Advanced/Metastatic  (3) Sarcoma  (2)